优化前列腺癌放疗使用间隔凝胶,体积调制电弧治疗和单一生物器官的危险目标

Q4 Health Professions
M. Pinkawa, C. Schubert, N. Escobar-Corral, Vanessa Berneking, M. Eble
{"title":"优化前列腺癌放疗使用间隔凝胶,体积调制电弧治疗和单一生物器官的危险目标","authors":"M. Pinkawa, C. Schubert, N. Escobar-Corral, Vanessa Berneking, M. Eble","doi":"10.18869/ACADPUB.IJRR.16.2.169","DOIUrl":null,"url":null,"abstract":"Background: The aim was to evaluate the benefit of technical advances for treatment planning: introduc on of a hydrogel spacer, VMAT (volumetric modulated arc therapy) and a single biological organ at risk objec ve for the rectum and bladder. Ini al standard was a step-and-shoot IMRT (intensity modulated radiotherapy) without a spacer and conven onal organ at risk objec ves. Materials and Methods: Treatment plans were calculated using IMRT and VMAT techniques before and a(er spacer injec on in 27 pa ents, respec vely. Conven onal organ at risk objec ves have been used for the op miza on of IMRT plans, only a single biological organ at risk objec ve for VMAT plans. VMAT vs. IMRT plans and plans before vs. a(er spacer injec on were compared. Results: VMAT plans and independently the spacer demonstrated improved dose homogeneity, whereas VMAT addi onally displayed improved dose conformity. The dose to the bladder and rectum could be significantly decreased applying the VMAT technique (mean rectum volumes of 14%/10%/5% in VMAT vs. 36%/24%/12% in IMRT within the 50Gy/60Gy/70Gy isodoses; p<0.01). NTCP for ≥grade 3 rectum toxicity could be accordingly decreased with the VMAT technique (3.6 vs. 0.9% for IMRT vs. VMAT; p<0.01) and the spacer gel (3.3 vs. 1.2% for plans without vs. with spacer gel; p<0.01) – only 0.3% with VMAT and spacer gel. Conclusion: In addi on to the decreased rectal dose following spacer injec on, VMAT with single biological organ at risk op miza on resulted in further dose reduc on to the organs at risk and improved dose homogeneity and conformity in comparison to the step-and-shoot IMRT technique with conven onal objec ves.","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":"16 1","pages":"169-176"},"PeriodicalIF":0.0000,"publicationDate":"2018-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Optimization of prostate cancer radiotherapy using of a spacer gel, volumetric modulated arc therapy and a single biological organ at risk objective\",\"authors\":\"M. Pinkawa, C. Schubert, N. Escobar-Corral, Vanessa Berneking, M. Eble\",\"doi\":\"10.18869/ACADPUB.IJRR.16.2.169\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The aim was to evaluate the benefit of technical advances for treatment planning: introduc on of a hydrogel spacer, VMAT (volumetric modulated arc therapy) and a single biological organ at risk objec ve for the rectum and bladder. Ini al standard was a step-and-shoot IMRT (intensity modulated radiotherapy) without a spacer and conven onal organ at risk objec ves. Materials and Methods: Treatment plans were calculated using IMRT and VMAT techniques before and a(er spacer injec on in 27 pa ents, respec vely. Conven onal organ at risk objec ves have been used for the op miza on of IMRT plans, only a single biological organ at risk objec ve for VMAT plans. VMAT vs. IMRT plans and plans before vs. a(er spacer injec on were compared. Results: VMAT plans and independently the spacer demonstrated improved dose homogeneity, whereas VMAT addi onally displayed improved dose conformity. The dose to the bladder and rectum could be significantly decreased applying the VMAT technique (mean rectum volumes of 14%/10%/5% in VMAT vs. 36%/24%/12% in IMRT within the 50Gy/60Gy/70Gy isodoses; p<0.01). NTCP for ≥grade 3 rectum toxicity could be accordingly decreased with the VMAT technique (3.6 vs. 0.9% for IMRT vs. VMAT; p<0.01) and the spacer gel (3.3 vs. 1.2% for plans without vs. with spacer gel; p<0.01) – only 0.3% with VMAT and spacer gel. Conclusion: In addi on to the decreased rectal dose following spacer injec on, VMAT with single biological organ at risk op miza on resulted in further dose reduc on to the organs at risk and improved dose homogeneity and conformity in comparison to the step-and-shoot IMRT technique with conven onal objec ves.\",\"PeriodicalId\":14498,\"journal\":{\"name\":\"Iranian Journal of Radiation Research\",\"volume\":\"16 1\",\"pages\":\"169-176\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian Journal of Radiation Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18869/ACADPUB.IJRR.16.2.169\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Health Professions\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Radiation Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18869/ACADPUB.IJRR.16.2.169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 1

摘要

背景:目的是评估技术进步对治疗计划的益处:引入水凝胶间隔物、VMAT(体积调制电弧疗法)和直肠和膀胱的单一危险生物器官。国际标准是在没有间隔物和危险目标的常规器官的情况下分步发射IMRT(强度调制放射治疗)。材料和方法:治疗计划在治疗前使用IMRT和VMAT技术进行计算,并分别在27例患者中使用间隔物。IMRT计划的操作使用了传统的危险器官,VMAT计划仅使用单一的危险生物器官。VMAT与。比较了IMRT计划和注射前与注射后的IMRT计划。结果:VMAT计划和独立的间隔物显示出改善的剂量均匀性,而VMAT额外显示出改进的剂量一致性。应用VMAT技术可以显著降低膀胱和直肠的剂量(在50Gy/60Gy/70Gy等剂量范围内,VMAT的平均直肠体积为14%/10%/5%,IMRT的平均直肠容量为36%/24%/12%;p<0.01)。VMAT技术(IMRT与VMAT的3.6 vs.0.9%;p<0.01)和间隔凝胶(不使用间隔凝胶与使用间隔凝胶的计划的3.3 vs.1.2%;p<0.01)可相应降低NTCP对≥3级直肠毒性的影响——VMAT和间隔凝胶仅为0.3%。结论:除了间隔注射后直肠剂量减少外,与常规目标的分步注射IMRT技术相比,单一危险生物器官操作的VMAT进一步减少了对危险器官的剂量,提高了剂量的均匀性和一致性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Optimization of prostate cancer radiotherapy using of a spacer gel, volumetric modulated arc therapy and a single biological organ at risk objective
Background: The aim was to evaluate the benefit of technical advances for treatment planning: introduc on of a hydrogel spacer, VMAT (volumetric modulated arc therapy) and a single biological organ at risk objec ve for the rectum and bladder. Ini al standard was a step-and-shoot IMRT (intensity modulated radiotherapy) without a spacer and conven onal organ at risk objec ves. Materials and Methods: Treatment plans were calculated using IMRT and VMAT techniques before and a(er spacer injec on in 27 pa ents, respec vely. Conven onal organ at risk objec ves have been used for the op miza on of IMRT plans, only a single biological organ at risk objec ve for VMAT plans. VMAT vs. IMRT plans and plans before vs. a(er spacer injec on were compared. Results: VMAT plans and independently the spacer demonstrated improved dose homogeneity, whereas VMAT addi onally displayed improved dose conformity. The dose to the bladder and rectum could be significantly decreased applying the VMAT technique (mean rectum volumes of 14%/10%/5% in VMAT vs. 36%/24%/12% in IMRT within the 50Gy/60Gy/70Gy isodoses; p<0.01). NTCP for ≥grade 3 rectum toxicity could be accordingly decreased with the VMAT technique (3.6 vs. 0.9% for IMRT vs. VMAT; p<0.01) and the spacer gel (3.3 vs. 1.2% for plans without vs. with spacer gel; p<0.01) – only 0.3% with VMAT and spacer gel. Conclusion: In addi on to the decreased rectal dose following spacer injec on, VMAT with single biological organ at risk op miza on resulted in further dose reduc on to the organs at risk and improved dose homogeneity and conformity in comparison to the step-and-shoot IMRT technique with conven onal objec ves.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Iranian Journal of Radiation Research
Iranian Journal of Radiation Research RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
0.67
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: Iranian Journal of Radiation Research (IJRR) publishes original scientific research and clinical investigations related to radiation oncology, radiation biology, and Medical and health physics. The clinical studies submitted for publication include experimental studies of combined modality treatment, especially chemoradiotherapy approaches, and relevant innovations in hyperthermia, brachytherapy, high LET irradiation, nuclear medicine, dosimetry, tumor imaging, radiation treatment planning, radiosensitizers, and radioprotectors. All manuscripts must pass stringent peer-review and only papers that are rated of high scientific quality are accepted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信